Skip Nav Destination

Regression of established pulmonary metastases and subcutaneous tumor mediated by the systemic administration of high-dose recombinant interleukin 2.

J Exp Med (1985) 161 (5): 1169–1188.
Currently there are no citedby results. Try again later.